Research
Energy balance
Endoscopic Sleeve Gastroplasty (ESG) achieves 16-20% total weight loss at 12 months and improves metabolic markers without worsening GERD.
ESG is a minimally invasive procedure that reduces stomach size by 70-80% using sutures. It achieves 16-20% weight loss at one year and improves blood pressure and diabetes markers. Unlike some surgeries, it does not typically worsen acid reflux. It is suitable for those with a BMI of 30-50 who want a less invasive option than traditional surgery.
GoodSupportsHIGH confidence
Current evidence shows total weight loss effectiveness between 16% and 20% at 12 months, along with statistically significant reductions in blood pressure, waist circumference, triglycerides, glycated hemoglobin (HbA1c) levels, and hepatic steatosis index... it does not induce de novo gastroesophageal reflux disease (GERD) symptoms nor worsen existing GERD
Why this rating
Based on cited prospective trials and meta-analyses.
Source
Obesidad, el papel del gastroenterólogo
Valeria Atenea Costa et al. · Revista Colombiana de Gastroenterología · 2024
DOI 10.22516/25007440.1192
narrative_reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Semaglutide 2.4 mg weekly reduces cardiovascular mortality, myocardial infarction, and stroke in overweight/obese patients without diabetes but with cardiovascular disease.Strong
- Phentermine-topiramate produces greater weight loss than GLP-1 receptor agonists, but GLP-1 agonists carry a higher risk of adverse events.Good
- Intragastric balloons (IGB) are effective for weight loss but carry risks of dehydration, readmission, and reintervention, with saline-filled balloons outperforming air-filled ones.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →